M Holdings Securities, Inc. Viatris Inc Transaction History

M Holdings Securities, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$10.05 - $12.02 $134,941 - $161,392	13,427 New	13,427 $143,000
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $7,911 - $10,543	-860 Reduced 6.58%	12,211 $117,000
Q4 2022 Feb 10, 2023	SELL	$8.72 - $11.56 $7,159 - $9,490	-821 Reduced 5.91%	13,071 $145,000
Q3 2022 Nov 16, 2022	SELL	$8.48 - $11.13 $966 - $1,268	-114 Reduced 0.81%	13,892 $118,000
Q2 2022 Aug 16, 2022	SELL	$9.95 - $12.27 $9,671 - $11,926	-972 Reduced 6.49%	14,006 $147,000
Q1 2022 May 24, 2022	BUY	$9.81 - $15.4 $7,141 - $11,211	728 Added 5.11%	14,978 $163,000
Q2 2021 Aug 19, 2021	BUY	$12.97 - $16.15 $184,822 - $230,137	14,250 New	14,250 $204,000

1,141

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.5B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.